Photo from archive.org
Abstract The clinical and epidemiologic management of the SARS-CoV-2 pandemic is critically dependent on molecular assays with short turn-around time. We validated the novel Xpert Xpress SARS-CoV-2 assay using a… Click to show full abstract
Abstract The clinical and epidemiologic management of the SARS-CoV-2 pandemic is critically dependent on molecular assays with short turn-around time. We validated the novel Xpert Xpress SARS-CoV-2 assay using a commercial nucleic acid testing (Roche Cobas 6800). We found an excellent concordance over a range of SARS-CoV-2 loads and across established human coronaviruses.
Keywords:
validation novel;
xpress sars;
novel genexpert;
sars cov;
brief validation
Journal Title: Journal of Virological Methods
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Virological Methods
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!